Mark A. Demitrack
2023
In 2023, Mark A. Demitrack earned a total compensation of $1M as SVP and Chief Medical Officer at Trevena, a 50% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $218,025 |
|---|---|
| Salary | $510,120 |
| Stock Awards | $290,850 |
| Other | $13,200 |
| Total | $1,032,195 |
Demitrack received $510.1K in salary, accounting for 49% of the total pay in 2023.
Demitrack also received $218K in non-equity incentive plan, $290.9K in stock awards and $13.2K in other compensation.
Rankings
In 2023, Mark A. Demitrack's compensation ranked 1,170th out of 2,978 executives tracked by ExecPay. In other words, Demitrack earned more than 60.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,170 out of 2,978 | 61st |
Division Manufacturing | 697 out of 1,637 | 57th |
Major group Chemicals And Allied Products | 465 out of 906 | 49th |
Industry group Drugs | 454 out of 869 | 48th |
Industry Pharmaceutical Preparations | 312 out of 627 | 50th |
Source: SEC filing on April 29, 2024.
Demitrack's colleagues
We found two more compensation records of executives who worked with Mark A. Demitrack at Trevena in 2023.